​

Funding Round

Series B - NextPoint Therapeutics

Series B - NextPoint Therapeutics

Investment Firm

Overview

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Announced Date

Feb 14, 2024

Closed on Date

Feb 14, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Catalio Capital Management

Catalio Capital Management

Catalio Capital Management is a debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorArkin Holdings
Participant InvestorCatalio Capital Management
Participant InvestorSanofi Ventures
Participant InvestorMPM Capital
Participant InvestorInvus

Round Details and Background

NextPoint Therapeutics raised $42500000 on 2024-02-14 in Series B

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 10, 2023
Series B - NextPoint Therapeutics
9-80.0M
Feb 14, 2024
Series B - NextPoint Therapeutics
10-42.5M

Recent Activity

There is no recent news or activity for this profile.